Activin and Inhibin

B022 is a potent and selective NF-κB-inducing kinase (NIK) inhibitor ( K i of 4.2 nM: IC 50 =15.1 nM). B022 protects liver from toxin-induced inflammation, oxidative stress, and injuryIn VitroB022 (0-5 μM: 12 hours: Hepa1 cells) treatment suppresses

B022 is a potent and selective NF-κB-inducing kinase (NIK) inhibitor ( K i of 4.2 nM: IC 50 =15.1 nM). B022 protects liver from toxin-induced inflammation, oxidative stress, and injuryIn VitroB022 (0-5 μM: 12 hours: Hepa1 cells) treatment suppresses

BACE1-IN-1 is a potent and highly brain penetrant BACE1 inhibitor with IC 50 s of 32 and 47 nM for human BACE1 and BACE2 , respectively.Form:SolidIC50&amp: Target:IC50: 32 nM (human BACE1), 47 nM (human BACE2).

BACE1-IN-1 is a potent and highly brain penetrant BACE1 inhibitor with IC 50 s of 32 and 47 nM for human BACE1 and BACE2 , respectively.Form:SolidIC50&amp: Target:IC50: 32 nM (human BACE1), 47 nM (human BACE2).

BACE1-IN-1 is a potent and highly brain penetrant BACE1 inhibitor with IC 50 s of 32 and 47 nM for human BACE1 and BACE2 , respectively.Form:SolidIC50&amp: Target:IC50: 32 nM (human BACE1), 47 nM (human BACE2).

BAMB-4 (ITPKA-IN-C14) is a specific and membrane-permeable ITPKA inhibitor. BAMB-4 has high stability and membrane permeability and against the inositol-1,4,5-trisphosphate (InsP3) kinase activity of inositol-1,4,5-trisphosphate-3-kinase A (ITPKA)

BAMB-4 (ITPKA-IN-C14) is a specific and membrane-permeable ITPKA inhibitor. BAMB-4 has high stability and membrane permeability and against the inositol-1,4,5-trisphosphate (InsP3) kinase activity of inositol-1,4,5-trisphosphate-3-kinase A (ITPKA)

BAMB-4 (ITPKA-IN-C14) is a specific and membrane-permeable ITPKA inhibitor. BAMB-4 has high stability and membrane permeability and against the inositol-1,4,5-trisphosphate (InsP3) kinase activity of inositol-1,4,5-trisphosphate-3-kinase A (ITPKA)

BAMB-4 (ITPKA-IN-C14) is a specific and membrane-permeable ITPKA inhibitor. BAMB-4 has high stability and membrane permeability and against the inositol-1,4,5-trisphosphate (InsP3) kinase activity of inositol-1,4,5-trisphosphate-3-kinase A (ITPKA)

BAMB-4 (ITPKA-IN-C14) is a specific and membrane-permeable ITPKA inhibitor. BAMB-4 has high stability and membrane permeability and against the inositol-1,4,5-trisphosphate (InsP3) kinase activity of inositol-1,4,5-trisphosphate-3-kinase A (ITPKA)

BAN ORL 24 is a nociceptin/orphanin FQ (N/OFQ) peptide receptor (NOP) antagonist. BAN ORL 24 has antagonistic effect for nociceptin (NOP) receptor with K I value of 0.24 nM in CHO cell. BAN ORL 24 can be used for the research of cancer and

BAN ORL 24 is a nociceptin/orphanin FQ (N/OFQ) peptide receptor (NOP) antagonist. BAN ORL 24 has antagonistic effect for nociceptin (NOP) receptor with K I value of 0.24 nM in CHO cell. BAN ORL 24 can be used for the research of cancer and